Rituximab Therapy in Greek Patients With Rheumatoid Arthritis

Biologics: Targets and Therapy - New Zealand
doi 10.2147/btt.s3939
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Informa UK Limited

Related search

Factors Correlated With Improvement of Endothelial Dysfunction During Rituximab Therapy in Patients With Rheumatoid Arthritis

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2013English

Safety of Rituximab in Rheumatoid Arthritis

Reumatismo
Rheumatology
2011English

Serological Markers Associated With Disease Activity in Patients With Rheumatoid Arthritis Treated With Rituximab

Journal of International Medical Research
BiochemistryMedicineCell Biology
2016English

FRI0224 Rituximab Selectively Reduces Igg4 Levels in Rheumatoid Arthritis Patients

2017English

Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials

Journal of Rheumatology
RheumatologyAllergyImmunology
2010English

B Cell Therapy for Rheumatoid Arthritis: The Rituximab (Anti-Cd20) Experience

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2003English

Melatonin as an Adjuvant Therapy in Patients With Rheumatoid Arthritis

British Journal of Clinical Pharmacology
Pharmacology
2008English

NK Cell Count as Predictor of Clinical Response in Patients With Rheumatoid Arthritis Treated With Rituximab

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2012English

Clinical and Immunological Effects of the Original and Biosimilar Rituximab in Patients With Rheumatoid Arthritis

Clinical pharmacology and therapy
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy